Guiding lupus clinical management: The methodology behind guideline development

Guiding lupus clinical management: Hematologic manifestations

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital, Maria Dall'Era and Guillermo Pons-Estel as they discuss ACR and EULAR guidance on hematological manifestations of lupus and lupus nephritis, along with what that means in practice.

Marc Scherlinger Author Interview: June, 2026

Join Ed Vital, from the University of Leeds, United Kingdom, and Marc Scherlinger, from Strasbourg University Hospital, as they discuss his recent paper ‘Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study’.

Discussing Lupus: Emerging therapies in SLE and lupus nephritis

Dr Guillermo J. Pons-Estel and Professor Victoria Werth highlight the latest advances in lupus treatment. This podcast discusses the efficacy and safety of dapirolizumab pegol in patients with systemic lupus erythematosus, alongside new analyses demonstrating improved kidney outcomes with belimumab plus mycophenolate mofetil in lupus nephritis. If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

Guiding lupus clinical management: The methodology behind guideline development

Tune into this episode of our 'Guiding Lupus Clinical Management' podcast series and hear from Professors Ed Vital and Maria Dall'Era as they take a closer look at the ACR and EULAR guideline development models and consider their methodological strengths and differences, and point to additional resources.

Discussing Lupus: Anifrolumab and Belimumab in Systemic Lupus Erythematosus

Professor Ed Vital and Professor Chris Edwards discuss two recent studies advancing the treatment landscape in SLE. This episode discusses real-world effectiveness of anifrolumab in moderate-to-severe SLE and belimumab in SLE with haematological manifestations. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of lupus care. To explore the full papers and download accompanying slide decks, visit the Lupus Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: https://lupus-forum.com/